Fulgent Genetics Management
Management criteria checks 2/4
Fulgent Genetics' CEO is Ming Hsieh, appointed in May 2016, has a tenure of 8.5 years. total yearly compensation is $5.31M, comprised of 18.8% salary and 81.2% bonuses, including company stock and options. directly owns 28.8% of the company’s shares, worth €183.29M. The average tenure of the management team and the board of directors is 4.7 years and 3.8 years respectively.
Key information
Ming Hsieh
Chief executive officer
US$5.3m
Total compensation
| CEO salary percentage | 18.8% |
| CEO tenure | 8.5yrs |
| CEO ownership | 28.8% |
| Management average tenure | 4.7yrs |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$163m |
| Mar 31 2024 | n/a | n/a | -US$166m |
| Dec 31 2023 | US$5m | US$1m | -US$168m |
| Sep 30 2023 | n/a | n/a | -US$64m |
| Jun 30 2023 | n/a | n/a | -US$49m |
| Mar 31 2023 | n/a | n/a | -US$26m |
| Dec 31 2022 | US$5m | US$948k | US$143m |
| Sep 30 2022 | n/a | n/a | US$272m |
| Jun 30 2022 | n/a | n/a | US$392m |
| Mar 31 2022 | n/a | n/a | US$461m |
| Dec 31 2021 | US$6m | US$664k | US$507m |
| Sep 30 2021 | n/a | n/a | US$569m |
| Jun 30 2021 | n/a | n/a | US$493m |
| Mar 31 2021 | n/a | n/a | US$417m |
| Dec 31 2020 | US$248k | US$240k | US$214m |
| Sep 30 2020 | n/a | n/a | US$48m |
| Jun 30 2020 | n/a | n/a | US$3m |
| Mar 31 2020 | n/a | n/a | -US$459k |
| Dec 31 2019 | US$240k | US$240k | -US$411k |
| Sep 30 2019 | n/a | n/a | -US$2m |
| Jun 30 2019 | n/a | n/a | -US$4m |
| Mar 31 2019 | n/a | n/a | -US$6m |
| Dec 31 2018 | US$240k | US$240k | -US$6m |
| Sep 30 2018 | n/a | n/a | -US$5m |
| Jun 30 2018 | n/a | n/a | -US$6m |
| Mar 31 2018 | n/a | n/a | -US$5m |
| Dec 31 2017 | US$240k | US$240k | -US$3m |
Compensation vs Market: Ming's total compensation ($USD5.31M) is above average for companies of similar size in the German market ($USD1.43M).
Compensation vs Earnings: Ming's compensation has increased whilst the company is unprofitable.
CEO
Ming Hsieh (68 yo)
8.5yrs
Tenure
US$5,309,167
Compensation
Mr. Ming Hsieh has been an Independent Director of Fortinet, Inc. since April 2013. He is the Founder of Fulgent Genetics, Inc. and had been its President until May 2022 & serves as its Chief Executive Off...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 8.5yrs | US$5.31m | 28.8% € 183.3m | |
| COO & President | 6.6yrs | US$1.79m | 1.43% € 9.1m | |
| Chief Financial Officer | 8.8yrs | US$1.78m | 0.40% € 2.6m | |
| Chief Scientific Officer & Laboratory Director | 8.2yrs | US$1.49m | 2.82% € 18.0m | |
| General Counsel & Chief Privacy Officer | 2.5yrs | no data | no data | |
| VP of Operations & Compliance and GM of Houston Office | 4.1yrs | no data | no data | |
| Vice President of Business Development & Sales | 9.8yrs | no data | no data | |
| Vice President of Human Resources | 2.5yrs | no data | no data | |
| Chief Commercial Officer | 4.7yrs | no data | no data | |
| Chief Medical Officer | 3.5yrs | no data | no data | |
| President & Chief Scientific Officer of Fulgent Pharma | 2yrs | no data | no data |
4.7yrs
Average Tenure
58yo
Average Age
Experienced Management: 7F0's management team is considered experienced (4.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 8.5yrs | US$5.31m | 28.8% € 183.3m | |
| Independent Non-Employee Director | 1.8yrs | US$625.60k | 0.0039% € 24.9k | |
| Independent Director | 5.3yrs | US$270.50k | 0.062% € 392.0k | |
| Independent Non-Employee Director | 2.3yrs | US$268.50k | 0.0079% € 50.0k |
3.8yrs
Average Tenure
67yo
Average Age
Experienced Board: 7F0's board of directors are considered experienced (3.8 years average tenure).